Clinical Trial: Emtricitabine for Naive Chinese Chronic Hepatitis B Patients

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: Emtricitabine for Naive Chinese Chronic Hepatitis B Patients

Brief Summary: This study evaluates generic emtricitabine(FTC) in Chinese naive chronic hepatitis B patients. Patients were divided into 2 groups: HBeAg positive Chronic hepatitis B(CHB)group and HBeAg negative Chronic hepatitis B(CHB)group.